Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionalpha-actinin binding

DAG1 PPARG ALMS1 XIRP2

1.55e-0531984GO:0051393
GeneOntologyMolecularFunctionactinin binding

DAG1 PPARG ALMS1 XIRP2

5.81e-0543984GO:0042805
GeneOntologyMolecularFunctioncytoskeletal protein binding

ANK2 MAP1B SYNM MYO7B DAG1 SYNPO PPARG PRC1 EPB41L3 CLSTN1 SHROOM2 ALMS1 XIRP2 NISCH RAB11FIP5

2.91e-0410999815GO:0008092
GeneOntologyCellularComponentalveolar lamellar body membrane

ABCA3 TMEM63B

6.64e-053992GO:0097233
GeneOntologyCellularComponentlamellar body membrane

ABCA3 TMEM63B

1.32e-044992GO:0097232
GeneOntologyCellularComponentcostamere

ANK2 SYNM DAG1

1.49e-0422993GO:0043034
GeneOntologyCellularComponentsuper elongation complex

AFF3 EAF1

3.29e-046992GO:0032783
GeneOntologyCellularComponentspine apparatus

SYNPO CLSTN1

7.82e-049992GO:0097444
GeneOntologyCellularComponentbasal dendrite

MAP1B SLC17A8

9.75e-0410992GO:0097441
GeneOntologyCellularComponentalveolar lamellar body

ABCA3 TMEM63B

9.75e-0410992GO:0097208
DomainCadherin-like

DAG1 PCDHAC2 PCDH12 CLSTN1 FAT1

3.47e-04116975IPR015919
DomainMYTH4

MYO7B PLEKHH1

9.39e-049972PS51016
DomainMyTH4_dom

MYO7B PLEKHH1

9.39e-049972IPR000857
DomainMyTH4

MYO7B PLEKHH1

9.39e-049972PF00784
DomainMyTH4

MYO7B PLEKHH1

9.39e-049972SM00139
Domain-

TRIO MYO7B RALGPS2 CNKSR2 EPB41L3 PLEKHH1 ASAP2 ARHGEF26

9.80e-043919782.30.29.30
DomainPH

TRIO RALGPS2 CNKSR2 PLEKHH1 ASAP2 ARHGEF26

1.24e-03229976PF00169
DomainIGc2

MXRA5 TRIO IGDCC3 PTPRF SIGLEC11 LILRA4

1.42e-03235976SM00408
DomainIg_sub2

MXRA5 TRIO IGDCC3 PTPRF SIGLEC11 LILRA4

1.42e-03235976IPR003598
DomainGalactose-bd-like

MANBA PTPRM SUCO DCBLD2

1.46e-0394974IPR008979
DomainIG

MXRA5 TRIO IGDCC3 PTPRF PTPRM VCAN SIGLEC11 LILRA4

1.57e-03421978SM00409
DomainIg_sub

MXRA5 TRIO IGDCC3 PTPRF PTPRM VCAN SIGLEC11 LILRA4

1.57e-03421978IPR003599
DomainPH_dom-like

TRIO MYO7B RALGPS2 CNKSR2 EPB41L3 PLEKHH1 ASAP2 ARHGEF26

1.69e-03426978IPR011993
DomainFERM_M

MYO7B EPB41L3 PLEKHH1

1.75e-0346973PF00373
Domain-

MYO7B EPB41L3 PLEKHH1

2.10e-03499731.20.80.10
DomainFERM_central

MYO7B EPB41L3 PLEKHH1

2.10e-0349973IPR019748
DomainFERM_domain

MYO7B EPB41L3 PLEKHH1

2.10e-0349973IPR000299
DomainFERM_1

MYO7B EPB41L3 PLEKHH1

2.23e-0350973PS00660
DomainFERM_2

MYO7B EPB41L3 PLEKHH1

2.23e-0350973PS00661
DomainFERM_3

MYO7B EPB41L3 PLEKHH1

2.23e-0350973PS50057
DomainBand_41_domain

MYO7B EPB41L3 PLEKHH1

2.23e-0350973IPR019749
DomainB41

MYO7B EPB41L3 PLEKHH1

2.23e-0350973SM00295
DomainFERM/acyl-CoA-bd_prot_3-hlx

MYO7B EPB41L3 PLEKHH1

2.23e-0350973IPR014352
Domain-

NDNF MXRA5 TRIO DAG1 IGDCC3 PTPRF PTPRM VCAN SIGLEC11 LILRA4

2.32e-0366397102.60.40.10
DomainCADHERIN_1

PCDHAC2 PCDH12 CLSTN1 FAT1

2.86e-03113974PS00232
DomainCadherin

PCDHAC2 PCDH12 CLSTN1 FAT1

2.86e-03113974PF00028
DomainCADHERIN_2

PCDHAC2 PCDH12 CLSTN1 FAT1

2.95e-03114974PS50268
Domain-

PCDHAC2 PCDH12 CLSTN1 FAT1

2.95e-031149742.60.40.60
DomainCA

PCDHAC2 PCDH12 CLSTN1 FAT1

3.04e-03115974SM00112
DomainIg_I-set

MXRA5 TRIO IGDCC3 PTPRF SIGLEC11

3.13e-03190975IPR013098
DomainI-set

MXRA5 TRIO IGDCC3 PTPRF SIGLEC11

3.13e-03190975PF07679
DomainPH

TRIO RALGPS2 CNKSR2 PLEKHH1 ASAP2 ARHGEF26

3.29e-03278976SM00233
DomainCadherin

PCDHAC2 PCDH12 CLSTN1 FAT1

3.34e-03118974IPR002126
DomainPH_DOMAIN

TRIO RALGPS2 CNKSR2 PLEKHH1 ASAP2 ARHGEF26

3.35e-03279976PS50003
DomainPH_domain

TRIO RALGPS2 CNKSR2 PLEKHH1 ASAP2 ARHGEF26

3.40e-03280976IPR001849
DomainIg-like_fold

NDNF MXRA5 TRIO DAG1 IGDCC3 PTPRF PTPRM VCAN SIGLEC11 LILRA4

3.64e-037069710IPR013783
DomainIG_LIKE

MXRA5 TRIO IGDCC3 PTPRF PTPRM VCAN SIGLEC11 LILRA4

4.04e-03491978PS50835
DomainIg-like_dom

MXRA5 TRIO IGDCC3 PTPRF PTPRM VCAN SIGLEC11 LILRA4

4.66e-03503978IPR007110
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

MANBA MAP1B RBBP4 GPS1 DAG1 RRM1 CLSTN1 FAT1 MAN1A2 PTPRF TENM3 BCAP29 PRMT5 SCARB1 SUCO DCBLD2

2.83e-071201991635696571
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

ANK2 TRIO SYNPO CNKSR2 SIK3 EPB41L3 ASAP2 DYNC1H1

1.49e-0628199828706196
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

EPRS1 CIB1 ANK2 TRIO SYNM GPR37L1 SYNPO SHROOM2 PLEKHH1 MAN1A2 TPP1 NISCH GFPT2 CABIN1 DYNC1H1

3.53e-061285991535914814
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

MAP1B TRIO RBBP4 AFF3 HDAC8 TMEM63B BARD1 SYNPO SHROOM2 PLEKHH1 ASAP2 BCAP29 SCARB1 RBM5 NRG3 ARHGEF26

4.64e-061489991628611215
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

ANK2 RALGPS2 DAG1 ST14 FAT1 PTPRF PTPRM SCARB1 ARHGEF26 DCBLD2

5.37e-06569991030639242
Pubmed

Protein arginine methyltransferase 5 (Prmt5) promotes gene expression of peroxisome proliferator-activated receptor γ2 (PPARγ2) and its target genes during adipogenesis.

PPARG PRMT5

8.02e-06299222361822
Pubmed

CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.

GPS1 FAT1

8.02e-06299227325650
Pubmed

FBXW10 promotes hepatocarcinogenesis in male patients and mice.

FBXW10B FBXW10

8.02e-06299231400758
Pubmed

PPARγ inhibits breast cancer progression by upregulating PTPRF expression.

PPARG PTPRF

8.02e-06299231799666
Pubmed

PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.

MUC16 PPARG

8.02e-06299227292441
Pubmed

Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.

FBXW10B FBXW10

8.02e-06299237450367
Pubmed

Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes.

PPARG SCARB1

8.02e-06299219156545
Pubmed

Promoter-enhancer looping at the PPARγ2 locus during adipogenic differentiation requires the Prmt5 methyltransferase.

PPARG PRMT5

8.02e-06299226935580
Pubmed

The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains.

TRIO PTPRF

8.02e-0629928643598
Pubmed

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer.

BARD1 MUC16

8.02e-06299234201956
Pubmed

Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor γ protein, is essential for adipogenesis.

PPARG SND1

8.02e-06299224523408
Pubmed

Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer.

HPGD VCAN

8.02e-06299228320945
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

RALGPS2 RRM1 EPB41L3 SHROOM2 PRMT5 RAB11FIP5 DYNC1H1

8.80e-0625599715324660
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

EPRS1 MANBA RBBP4 GPS1 RRM1 EPB41L3 TPP1 PRMT5 SCARB1 UCK2

1.03e-05613991022268729
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

EFCAB6 SYNM MUC16 CNKSR2 EPB41L3 BLM FAT1 TENM3 RBM5 RAB11FIP5 DYNC1H1

1.37e-05777991135844135
Pubmed

Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

CCDC14 EFCAB6 GPS1 HDAC8 DAG1 SYNPO CNKSR2 RRM1 BLM NOP58 FAT1 BCAP29 TPP1 VCAN

1.79e-051293991415342556
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

ANK2 TRIO PAK5 SYNPO CNKSR2 SIK3 EPB41L3 VIRMA NISCH CABIN1 ARHGEF26 DYNC1H1

1.92e-05963991228671696
Pubmed

Three-dimensional visualization of testis cord morphogenesis, a novel tubulogenic mechanism in development.

AFF3 IGDCC3 SYNPO PRC1 MAN1A2 VCAN

2.15e-0519699619334288
Pubmed

Expression of 15-Hydroxyprostaglandin Dehydrogenase in Human Chorion Is Associated with Peroxisome Proliferator-Activated Receptor Isoform Expression in Term Labor.

PPARG HPGD

2.40e-05399226093984
Pubmed

Pilot study examining the frequency of several gene polymorphisms in a morbidly obese population.

PPARG SCARB1

2.40e-05399212568179
Pubmed

Cloning, expression and chromosomal localization of a new putative receptor-like protein tyrosine phosphatase.

PTPRF PTPRM

2.40e-0539921655529
Pubmed

Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages.

PPARG SCARB1

2.40e-05399221940512
Pubmed

Assignment of the centromere protein H (Cenph) gene to mouse chromosome band 13D1 by in situ hybridization and interspecific backcross analyses.

MAP1B VCAN

2.40e-05399211060445
Pubmed

Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha.

PPARG SCARB1

2.40e-05399212763030
Pubmed

BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution.

BARD1 BLM

2.40e-05399238266639
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

CCDC14 MAP1B TRIO GPS1 SYNPO SIK3 FAT1 SCARB1 GFPT2 THAP12

2.79e-05689991036543142
Pubmed

Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis.

RBBP4 PRC1 PRMT5

2.87e-052199330179224
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

MAP1B TRIO PAK5 RALGPS2 SIK3 EPB41L3 VIRMA ALMS1 PRMT5 RAB11FIP5 NCOA7

3.49e-05861991136931259
Pubmed

Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction.

PPARG HPGD

4.79e-05499231027998
Pubmed

SerThr-PhosphoProteome of Brain from Aged PINK1-KO+A53T-SNCA Mice Reveals pT1928-MAP1B and pS3781-ANK2 Deficits, as Hub between Autophagy and Synapse Changes.

ANK2 MAP1B

4.79e-05499231277379
Pubmed

Binding of microtubule-associated protein 1B to LIS1 affects the interaction between dynein and LIS1.

MAP1B DYNC1H1

4.79e-05499215762842
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

EPRS1 ANK2 MAP1B TRIO SYNPO CNKSR2 EPB41L3 SHROOM2 VIRMA SND1 PRMT5 NISCH VCAN DYNC1H1

5.40e-051431991437142655
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

TRIO RBBP4 CNKSR2 PRC1 EPB41L3 VIRMA NOP58 ASAP2 NISCH RBM5 ARHGEF26

6.10e-05916991132203420
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

ANK2 MAP1B GPR37L1 SYNPO CNKSR2 EPB41L3 RAB11FIP5

6.28e-0534799717114649
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

CCDC14 ANK2 TRIO CNKSR2 DYNC1H1

7.43e-0515199517043677
Pubmed

FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males.

FBXW10B FBXW10

7.98e-05599237277019
Pubmed

Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.

PTPRF PTPRM

7.98e-05599210777529
Pubmed

Capturing genes encoding membrane and secreted proteins important for mouse development.

FAT1 PTPRF

7.98e-0559927604039
Pubmed

Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation.

PPARG HPGD

7.98e-05599217449869
Pubmed

Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.

PPARG SCARB1

7.98e-05599225600616
Pubmed

An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.

ANK2 DAG1

7.98e-05599219109891
Pubmed

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

ANK2 TRIO SYNPO CNKSR2 EPB41L3 DYNC1H1

8.51e-0525199627507650
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

MXRA5 BARD1 MUC16 SIK3 VIRMA PLEKHH1 RAB11FIP5 GFPT2 ACSS3

8.88e-0563899931182584
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

CCDC14 MIS18BP1 MAP1B BARD1 PRC1 EPB41L3 WDR76 ALMS1 CABIN1

9.65e-0564599925281560
Pubmed

Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.

NDNF GPR37L1 PRC1 RRM1 PTPRM SLC17A8 RAB11FIP5

1.04e-0437699724154525
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

MAP1B RBBP4 EPB41L3 VIRMA BLM NOP58 SND1 PRMT5 DYNC1H1

1.06e-0465399922586326
Pubmed

ERAP140, a conserved tissue-specific nuclear receptor coactivator.

PPARG NCOA7

1.19e-04699211971969
Pubmed

DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes.

EAF1 PRMT5 RBM5

1.26e-043499332152128
Pubmed

ATRX proximal protein associations boast roles beyond histone deposition.

RBBP4 WDR76 BLM ZFHX4

1.37e-049199434780483
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

MIS18BP1 DAG1 VIRMA BLM NOP58 MAN1A2 PTPRF BCAP29 SCARB1 RAB11FIP5 DCBLD2 THAP12

1.61e-041203991229180619
Pubmed

Identification and typing of members of the protein-tyrosine phosphatase gene family expressed in mouse brain.

PTPRF PTPRM

1.67e-0479921454056
Pubmed

Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.

PTPRF PTPRM

1.67e-04799212376545
Pubmed

Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.

PTPRF VCAN

1.67e-04799221976490
Pubmed

Genetic analysis of intestinal cholesterol absorption in inbred mice.

PPARG SCARB1

1.67e-04799211714849
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

EPRS1 ANK2 MAP1B RRM1 EPB41L3 SND1 RAB11FIP5 ARHGEF26 DYNC1H1

1.94e-0470899939231216
Pubmed

Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation.

SND1 BCAP29 VCAN

2.05e-044099316210410
Pubmed

Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1.

EPRS1 BARD1

2.22e-04899236347866
Pubmed

A comprehensive resource of interacting protein regions for refining human transcription factor networks.

EPRS1 ANK2 MAP1B PPARG CLSTN1

2.23e-0419199520195357
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

SYNM ALMS1 CABIN1 DYNC1H1

2.28e-041049949205841
Pubmed

Molecular characterization of ENU mouse mutagenesis and archives.

BARD1 BLM

2.85e-04999216139793
Pubmed

Functional specialization of beta-arrestin interactions revealed by proteomic analysis.

MAP1B PAK5 EPB41L3 PRMT5 RAB11FIP5 DYNC1H1

3.01e-0431799617620599
Pubmed

ABCE1 is a highly conserved RNA silencing suppressor.

ANK2 MAP1B EPB41L3 PTPRF TPP1

3.02e-0420499525659154
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

MAP1B RBBP4 BARD1 PRC1 VIRMA BLM NOP58 C18orf21 SND1

3.23e-0475999935915203
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

MIS18BP1 RBBP4 BARD1 SYNPO WDR76 BLM NOP58 CABIN1

3.54e-0460899836089195
Pubmed

Concordance of two multiple analytical approaches demonstrate that interaction between BMI and ADIPOQ haplotypes is a determinant of LDL cholesterol in a general French population.

PPARG SCARB1

3.56e-041099220186155
Pubmed

The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.

FBXW10B FBXW10 ALMS1

3.98e-045099326275350
Pubmed

Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.

MAP1B RBBP4 WDR76 NOP58 VCAN

4.18e-0421999531353912
Pubmed

The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease.

CIB1 LCA5L AIDA PRMT5 RBM5

4.27e-0422099524705354
Pubmed

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.

EPRS1 PPARG

4.34e-041199235449157
Pubmed

Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells.

PRMT5 UCK2

4.34e-041199231938050
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

MIS18BP1 AFF3 BARD1 BLM NOP58

4.45e-0422299537071664
Pubmed

Proteomic analysis of in vivo phosphorylated synaptic proteins.

MAP1B EPB41L3 RAB11FIP5

4.73e-045399315572359
Pubmed

CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.

RBBP4 GPS1 PRMT5

4.73e-045399334026424
Pubmed

The Effect of the NFκB-USP9X-Cx43 Axis on the Dynamic Balance of Bone Formation/Degradation during Ossification of the Posterior Longitudinal Ligament of the Cervical Spine.

MAP1B SND1 PRMT5

4.99e-045499335391932
Pubmed

Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.

PTPRF PTPRM

5.20e-04129929624153
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

MAP1B PAK5 SYNPO CNKSR2 EPB41L3

5.33e-0423199516452087
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

EPB41L3 CLSTN1 ASAP2 ALMS1

5.33e-0413099412421765
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

EPRS1 RBBP4 BARD1 BLM ALMS1 SND1 PRMT5

5.41e-0449499726831064
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

SAMSN1 SHROOM2 PLEKHH1 ALMS1 XIRP2

5.54e-0423399537704626
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

EPRS1 MAP1B TRIO TENM3 PRMT5 DYNC1H1

5.72e-0435899632460013
Pubmed

USP45 and Spindly are part of the same complex implicated in cell migration.

EPRS1 CLSTN1 ASAP2 PRMT5 VCAN

5.76e-0423599530258100
Pubmed

Applying gene expression, proteomics and single-nucleotide polymorphism analysis for complex trait gene identification.

PPARG SCARB1

6.13e-041399218245842
Pubmed

Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.

PPARG SCARB1

7.14e-041499212039952
Pubmed

MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

RBBP4 PRMT5

7.14e-041499216428440
Pubmed

Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.

ABCA3 EPB41L3 SND1 BCAP29 SCARB1 SUCO

7.28e-0437599632788342
Pubmed

rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions.

RBBP4 PRC1 NOP58 RBM5

7.42e-0414299430217970
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

DAG1 EPB41L3 PTPRF PTPRM SCARB1 RAB11FIP5

7.49e-0437799638117590
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

MAP1B PPARG PRC1 BLM XYLT1 ZFHX4 NISCH CABIN1 DYNC1H1

7.70e-0485799925609649
Pubmed

Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.

EPRS1 NOP58 SND1 DYNC1H1

7.82e-0414499435681168
Pubmed

A systematic gene-based screen of chr4q22-q32 identifies association of a novel susceptibility gene, DKK2, with the quantitative trait of alcohol dependence symptom counts.

NDNF MANBA ANK2

8.22e-046499320332099
Pubmed

Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface.

MANBA MAN1A2

8.22e-04159928892864
Pubmed

Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.

EPRS1 MAP1B RBBP4 PRC1 SND1 RBM5

8.24e-0438499631059266
Pubmed

Cloning and characterization of PTP-K1, a novel nonreceptor protein tyrosine phosphatase highly expressed in bone marrow.

PTPRF PTPRM

9.38e-04169928875997
Pubmed

Expression of aldehyde dehydrogenase family 1, member A3 in glycogen trophoblast cells of the murine placenta.

PPARG PCDH12

9.38e-041699225577283
Pubmed

Screening for replication of genome-wide SNP associations in sporadic ALS.

MAN1A2 HPGD

9.38e-041699218987618
InteractionKALRN interactions

ANK2 TRIO SYNPO CNKSR2 EPB41L3 VIRMA

6.16e-0696956int:KALRN
InteractionTNPO1 interactions

MAP1B RBBP4 GPS1 TMEM63B SIK3 RRM1 VIRMA PTPRM SUCO

1.43e-05306959int:TNPO1
InteractionSHANK3 interactions

ANK2 MAP1B GPS1 SYNPO CNKSR2 PRC1 EPB41L3 VIRMA XIRP2 RBM5 DYNC1H1

2.18e-054969511int:SHANK3
InteractionGAN interactions

MXRA5 MAP1B PAK5 WDR76 VIRMA ALMS1 TENM3 PRMT5

2.62e-05253958int:GAN
InteractionAGRN interactions

MAP1B DAG1 WDR76 VIRMA ASAP2 OLFM3 TENM3 SND1

3.84e-05267958int:AGRN
InteractionATRX interactions

ANK2 PRC1 EPB41L3 VIRMA BLM EAF1 ZFHX4 CABIN1

3.84e-05267958int:ATRX
CytobandXp22.12

CNKSR2 BCLAF3

1.28e-048992Xp22.12
Cytoband1q41

EPRS1 AIDA DISP1

4.03e-04669931q41
Cytoband12q21.31

METTL25 ACSS3

6.89e-041899212q21.31
Cytoband2p25

TPO ASAP2

6.89e-04189922p25
CytobandEnsembl 112 genes in cytogenetic band chr15q26

CIB1 SYNM PRC1 BLM

1.06e-03206994chr15q26
CytobandEnsembl 112 genes in cytogenetic band chr1q41

EPRS1 AIDA DISP1

1.10e-0393993chr1q41
Cytoband2p13

ALMS1 RAB11FIP5

1.13e-03239922p13
CytobandEnsembl 112 genes in cytogenetic band chrXp22

MXRA5 CNKSR2 SHROOM2 BCLAF3

2.16e-03250994chrXp22
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MXRA5 TRIO IGDCC3 PTPRF PTPRM SIGLEC11

2.65e-05161666593
GeneFamilyWD repeat domain containing|F-box and WD repeat domain containing

FBXW10B FBXW10

7.07e-0411662559
GeneFamilyAnkyrin repeat domain containing|FERM domain containing

MYO7B EPB41L3 PLEKHH1

8.06e-04506631293
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

RALGPS2 CNKSR2 PLEKHH1 ASAP2 ARHGEF26

9.30e-04206665682
GeneFamilyCadherin related

CLSTN1 FAT1

1.72e-031766224
GeneFamilyProtein tyrosine phosphatases, receptor type

PTPRF PTPRM

2.64e-0321662813
GeneFamilySterile alpha motif domain containing

CNKSR2 BFAR SAMSN1

4.09e-0388663760
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL

TRIO SYNM RALGPS2 TMEM63B ASAP2 ZFHX4 TENM3 RBPMS2 NCOA7 GFPT2

1.59e-072949810M45674
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

MIS18BP1 BARD1 PRC1 RRM1 WDR76 ST14 BLM NOP58 FAT1 UCK2

2.72e-064029810MM454
CoexpressionGSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP

ABCA3 MIS18BP1 AFF3 SYNPO NOP58 UCK2 THAP12

9.77e-06198987M5044
CoexpressionGSE7852_LN_VS_THYMUS_TCONV_DN

MIS18BP1 HEMGN PRC1 RRM1 BLM PTPRF VCAN

1.04e-05200987M5746
CoexpressionPATIL_LIVER_CANCER

CCDC14 MAP1B TRIO GPS1 PPARG RRM1 CLSTN1 PTPRF UCK2 SUCO DYNC1H1

3.66e-056609811M1195
CoexpressionKAAB_HEART_ATRIUM_VS_VENTRICLE_UP

MAP1B SYNPO EPB41L3 XYLT1 SND1 VCAN LILRA4

5.07e-05256987M10952
CoexpressionTOYOTA_TARGETS_OF_MIR34B_AND_MIR34C

MIS18BP1 RBBP4 HDAC8 BARD1 BFAR ALMS1 BCAP29 ARHGEF26 THAP12

5.23e-05454989M19927
CoexpressionCUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE

EPRS1 DAG1 FAT1 BCAP29 SUCO DCBLD2

5.84e-05179986M39308
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

NDNF CIB1 MAP1B TRIO RALGPS2 SYNPO BFAR SHROOM2 ALMS1 PTPRM TPP1 NISCH RBM5 CABIN1

6.01e-0511029814M2369
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP

MIS18BP1 RBBP4 AIDA PRC1 RRM1 WDR76 BLM NOP58 VCAN THAP12

6.19e-055789810M2368
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

NDNF CIB1 MAP1B TRIO RALGPS2 SYNPO BFAR SHROOM2 ALMS1 PTPRM TPP1 NISCH RBM5 CABIN1

7.42e-0511249814MM1070
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP

MIS18BP1 RBBP4 AIDA PRC1 RRM1 WDR76 BLM NOP58 VCAN THAP12

8.09e-055979810MM1309
CoexpressionGSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN

CNKSR2 MAN1A2 EAF1 PTPRM SLC17A8 NCOA7

9.36e-05195986M6142
CoexpressionGSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP

SAMSN1 XYLT1 SND1 PRMT5 UCK2 LILRA4

1.02e-04198986M3436
CoexpressionHALLMARK_MITOTIC_SPINDLE

TRIO SYNPO PRC1 SHROOM2 ALMS1 DYNC1H1

1.05e-04199986M5893
CoexpressionGSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN

RALGPS2 HEMGN BARD1 PRC1 RRM1 BLM

1.05e-04199986M6203
CoexpressionGSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN

MIS18BP1 SYNPO ST14 BLM NOP58 BCAP29

1.08e-04200986M5048
CoexpressionGSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN

BARD1 SYNPO PRC1 RRM1 ST14 BCAP29

1.08e-04200986M5052
CoexpressionFISCHER_G1_S_CELL_CYCLE

BARD1 WDR76 BLM MAN1A2 TENM3 NCOA7

1.08e-04200986M107
CoexpressionGSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN

MANBA MAP1B TMEM63B DAG1 TPP1 NISCH

1.08e-04200986M7868
CoexpressionGSE14350_IL2RB_KO_VS_WT_TEFF_DN

HEMGN PRC1 SHROOM2 HPGD VCAN METTL25

1.08e-04200986M3424
CoexpressionGSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN

CIB1 EFCAB6 TRIO AFF3 LCA5L BCLAF3

1.08e-04200986M5699
CoexpressionHUANG_DASATINIB_RESISTANCE_DN

ABCA3 PLEKHH1 SCARB1 ACSS3

1.39e-0470984M16369
CoexpressionRODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP

CCDC14 EPRS1 RBBP4 RALGPS2 PRC1 RRM1 WDR76 NOP58 MAN1A2 UCK2

1.50e-046449810M10501
CoexpressionFURUKAWA_DUSP6_TARGETS_PCI35_DN

PRC1 RRM1 BLM PRMT5

1.64e-0473984M7339
CoexpressionNABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS

MXRA5 MUC16 ST14

1.91e-0430983M47990
CoexpressionHEVNER_CORTEX_RADIAL_GLIA_PROGENITORS

MIS18BP1 DAG1 PRC1 BLM FAT1 MAN1A2 ZFHX4 SCARB1

2.20e-04432988MM419
CoexpressionBASSO_B_LYMPHOCYTE_NETWORK

MAP1B TPP1 NISCH RBM5 UCK2

2.24e-04146985M10633
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HRGL2B

NDNF BARD1 BCLAF3 XYLT1 FAT1 BCAP29 CABIN1 ARHGEF26

2.45e-04439988M39054
CoexpressionMIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN

SYNM AFF3 TENM3 VCAN GFPT2 DCBLD2

2.58e-04235986M2256
CoexpressionAtlasalpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM NOP58 ALMS1 PTPRF UCK2

1.26e-053979610GSM791143_500
CoexpressionAtlasalpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM NOP58 ALMS1 PTPRF UCK2

1.92e-054179610GSM399403_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200

MAP1B TRIO EPB41L3 MAN1A2 VCAN

2.29e-0575965DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200
CoexpressionAtlaskidney_P3_CapMes_Crym_top-relative-expression-ranked_1000

NDNF MIS18BP1 BARD1 CNKSR2 RRM1 BLM ALMS1 TENM3 PTPRM VCAN UCK2 ARHGEF26 DISP1

3.21e-057499613gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlasdev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000

MANBA MAP1B AFF3 RALGPS2 DAG1 FAT1 PTPRF ZFHX4 VCAN NCOA7 UCK2 SUCO DCBLD2

9.93e-058379613gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlasalpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM NOP58 PTPRF UCK2

1.06e-04413969GSM791149_500
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500

MIS18BP1 BARD1 WDR76 BCLAF3 BLM

1.15e-04105965gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500
CoexpressionAtlasalpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2

MIS18BP1 AFF3 BARD1 PRC1 RRM1 WDR76 BLM NOP58 UCK2

1.21e-04420969GSM791141_500
CoexpressionAtlasalpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3

MIS18BP1 AFF3 BARD1 PRC1 RRM1 WDR76 BLM NOP58 UCK2

1.21e-04420969GSM791136_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200

MAP1B TRIO EPB41L3 MAN1A2 ZFHX4 VCAN

1.23e-04170966DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4

MIS18BP1 EFCAB6 BARD1 SYNPO SAMSN1 ZFHX4 BCAP29 HPGD RAB11FIP5 CFAP74 ACSS3

1.81e-046559611Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4

EPRS1 MAP1B IGDCC3 WDR76 PLEKHH1

2.50e-04124965Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500

MAP1B TRIO EPB41L3 MAN1A2 VCAN DCBLD2

2.52e-04194966DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000

MAP1B TRIO BARD1 EPB41L3 MAN1A2 VCAN SUCO DCBLD2

2.70e-04369968DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlaskidney_P3_CapMes_Crym_top-relative-expression-ranked_500

NDNF BARD1 CNKSR2 TENM3 PTPRM VCAN ARHGEF26 DISP1

2.75e-04370968gudmap_kidney_P3_CapMes_Crym_500
CoexpressionAtlasalpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM PTPRF UCK2

3.07e-04376968GSM791154_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5

NDNF EPRS1 MAP1B IGDCC3 WDR76 NOP58

3.30e-04204966Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500

MIS18BP1 BARD1 CNKSR2 WDR76 BCLAF3 ALMS1 BCAP29 METTL25

3.59e-04385968gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500

MAP1B RBBP4 RRM1 EPB41L3 MAN1A2 VCAN

3.76e-04209966gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000

MAP1B EPB41L3 MAN1A2 VCAN SUCO DCBLD2

3.76e-04209966gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlasfacebase_RNAseq_e10.5_NeuroEpith_central_2500_K4

MIS18BP1 ANK2 MAP1B LCA5L TMEM63B IGDCC3 SIK3 SAMSN1 PRC1 WDR76 SHROOM2 XYLT1 FAT1 ALMS1 NRG3 METTL25

4.05e-0413709616facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlasdev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_500

MANBA DAG1 XYLT1 PTPRF NCOA7

4.10e-04138965gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_500
CoexpressionAtlasB cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3

MIS18BP1 AFF3 HDAC8 RALGPS2 BARD1 PRC1 RRM1 WDR76

4.26e-04395968GSM538340_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000

MAP1B RBBP4 RRM1 EPB41L3 MAN1A2 VCAN SUCO DCBLD2

4.40e-04397968gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100

MAP1B EPB41L3 VCAN

4.43e-0433963gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1
CoexpressionAtlasalpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM ALMS1 PTPRF

4.48e-04398968GSM399397_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500

NDNF MAP1B TRIO EPB41L3 MAN1A2 ZFHX4 VCAN DCBLD2

5.27e-04408968DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlasB cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3

MIS18BP1 RALGPS2 BARD1 PRC1 RRM1 WDR76 BLM ALMS1

5.36e-04409968GSM399452_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM PTPRF UCK2

5.80e-04414968GSM476660_500
CoexpressionAtlaskidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000

NDNF MIS18BP1 BARD1 CNKSR2 RRM1 BLM ALMS1

5.82e-04316967gudmap_kidney_P3_CapMes_Crym_k4_1000
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500

MIS18BP1 MAP1B RBBP4 HEMGN ZFHX4 PRMT5 NISCH RBM5

6.08e-04417968gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100

MAP1B EPB41L3 ZFHX4 VCAN

6.27e-0486964gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100
CoexpressionAtlasB cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM NOP58 UCK2

6.27e-04419968GSM538348_500
CoexpressionAtlasgamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3

MIS18BP1 BARD1 PRC1 RRM1 WDR76 ST14 BLM NOP58

6.27e-04419968GSM476664_500
CoexpressionAtlasfacebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4

NDNF AFF3 LCA5L SYNPO CNKSR2 SIK3 PPARG EPB41L3 TENM3 PTPRM HPGD VCAN RAB11FIP5 NRG3

6.35e-0411489614facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000

MAP1B RBBP4 BARD1 EPB41L3 MAN1A2 VCAN SUCO

7.51e-04330967DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200

MIS18BP1 RBBP4 DAG1 NISCH RBM5

7.81e-04159965gudmap_developingGonad_e12.5_epididymis_200
CoexpressionAtlaskidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000

NDNF BARD1 CNKSR2 PRC1 WDR76 ST14 BLM ALMS1 TENM3 VCAN UCK2

8.14e-047839611gudmap_kidney_P4_CapMesRenVes_Crym_1000
ToppCellCOVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type

TPO AFF3 PCDH12 SHROOM2 PTPRM HPGD SCARB1 NRG3

1.37e-081969984ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MXRA5 ANK2 MAP1B ZFHX4 TENM3 VCAN GFPT2

1.65e-07181997ab66a89f316b935d9ba1277426d976b1e9e39757
ToppCellIPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class

SYNM AFF3 SYNPO PCDH12 SHROOM2 HPGD NRG3

2.22e-07189997ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCellIPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class

SYNM AFF3 SYNPO PCDH12 SHROOM2 HPGD NRG3

2.30e-07190997b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NDNF SYNPO FAT1 TENM3 VCAN ARHGEF26 DCBLD2

2.65e-0719499743eb677a76634bb9a48a40e0d607c4936ae64bcc
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AFF3 XYLT1 ZFHX4 TENM3 VCAN ARHGEF26

2.74e-0719599749c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AFF3 XYLT1 ZFHX4 TENM3 VCAN ARHGEF26

2.74e-07195997dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AFF3 XYLT1 ZFHX4 TENM3 VCAN ARHGEF26

2.84e-071969973a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AFF3 XYLT1 ZFHX4 TENM3 VCAN ARHGEF26

2.84e-07196997bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type.

XYLT1 FAT1 MAN1A2 PTPRF ZFHX4 TPP1 VCAN

3.14e-07199997358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCellNon-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM ZFHX4

3.25e-072009974923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCellNon-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM ZFHX4

3.25e-07200997dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor

TPO SYNM PRC1 HPGD NRG3 DISP1

2.01e-061679965af9127bae05768a5164d5708a4ad37edca99324
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B BARD1 WDR76 BLM XYLT1 VCAN

2.31e-06171996b0373ed8283ee1792b6a490bff93906546978593
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B BARD1 WDR76 BLM XYLT1 VCAN

2.31e-06171996b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MIS18BP1 MANBA TRIO PPARG EPB41L3 VCAN

2.55e-06174996d5c22b43531414951666ee7542a66ed9380e2d14
ToppCellControl|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HTR1E AFF3 PCDH12 PTPRM HPGD DISP1

2.82e-06177996b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCellP28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GPR37L1 CNKSR2 EPB41L3 ZFHX4 TENM3 VCAN

3.11e-061809961e819c5c87704ec6535dfeaae56561895e239d07
ToppCellLPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PCDH12 PTPRM HPGD SCARB1 DISP1

3.11e-06180996544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

TPO AFF3 SHROOM2 PTPRM HPGD NRG3

3.21e-06181996c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFCAB6 MYO7B CNKSR2 FAT1 ZFHX4 XIRP2

3.52e-061849962cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFCAB6 MYO7B CNKSR2 FAT1 ZFHX4 XIRP2

3.52e-06184996ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFCAB6 MYO7B CNKSR2 FAT1 ZFHX4 XIRP2

3.52e-061849962b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PCDH12 PTPRM HPGD SCARB1 DISP1

3.99e-0618899673f6ec915934154f435a376cb274b058ff7c5f35
ToppCellfacs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK2 MAP1B EPB41L3 PTPRF TENM3 NISCH

3.99e-06188996a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

AFF3 SHROOM2 PTPRM HPGD NRG3 DISP1

4.11e-06189996b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCellRA-14._Fibroblast_III|World / Chamber and Cluster_Paper

SIK3 EPB41L3 XYLT1 FAT1 VCAN GFPT2

4.11e-06189996b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCellControl|World / Disease state, Lineage and Cell class

MANBA SIK3 PPARG SAMSN1 EPB41L3 VCAN

4.11e-06189996fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be
ToppCellAT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

NDNF ABCA3 TMEM63B PTPRF DCBLD2 ACSS3

4.11e-061899962d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK2 RALGPS2 XYLT1 TENM3 VCAN GFPT2

4.24e-0619099645df8fee00f8949937863159d7aa042e72748d9b
ToppCellFetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TPO PCDH12 HPGD SCARB1 NRG3 DISP1

4.37e-061919961de0bdfd13bd930691564c2673f2e66393bc0255
ToppCellCOVID-19_Severe-B_intermediate|World / disease group, cell group and cell class

ANK2 MYO7B AFF3 RALGPS2 SYNPO CNKSR2

4.37e-06191996f226fd69a26124ba98e4544f550b89a08e6a3708
ToppCellLPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PCDH12 ASAP2 PTPRM HPGD DISP1

4.50e-06192996c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCellEndothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor

TPO AFF3 PCDH12 HPGD SCARB1 NRG3

4.50e-061929961e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCellFetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

AFF3 PCDH12 HPGD SCARB1 NRG3 DISP1

4.50e-061929967197e401e563441ab94815f7619e032ebef9e586
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AFF3 CNKSR2 ZFHX4 GFPT2 ARHGEF26

4.64e-0619399609a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCellLA|World / Chamber and Cluster_Paper

MAP1B AFF3 EPB41L3 XYLT1 VCAN GFPT2

4.64e-06193996d4bf89437216baf489ea0239136dcedf3b6714af
ToppCellLPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PCDH12 ASAP2 PTPRM HPGD DISP1

4.78e-0619499643f92b0533e26633dc94cce554045d641ef8fd76
ToppCellRA|World / Chamber and Cluster_Paper

SIK3 SAMSN1 XYLT1 FAT1 VCAN NRG3

4.78e-0619499608f0afbb68a63150fbe107a5337299081c3f69e4
ToppCellLPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PCDH12 ASAP2 PTPRM HPGD DISP1

4.78e-061949961d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

NDNF PPARG ST14 BCLAF3 PTPRF ARHGEF26

4.78e-0619499688db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

NDNF PPARG ST14 BCLAF3 PTPRF ARHGEF26

4.78e-06194996a71728202493d4858342ea2756ea281cd0d99a3a
ToppCellfacs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM

4.92e-0619599693c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCellCOVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations)

HEMGN BARD1 PRC1 RRM1 WDR76 BLM

4.92e-06195996764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MAP1B PAK5 AFF3 CNKSR2 MAN1A2 NRG3

5.07e-06196996676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

MXRA5 MAP1B TRIO AFF3 CNKSR2 FAT1

5.07e-0619699624d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCellCOVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type

AFF3 PCDH12 SHROOM2 HPGD SCARB1 NRG3

5.07e-0619699649cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NDNF MXRA5 MAP1B IGDCC3 ZFHX4 TENM3

5.07e-0619699657df2a57b35be9851ac0b1e5731baa53052511f0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AFF3 XYLT1 ZFHX4 TENM3 ARHGEF26

5.22e-0619799609946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

NDNF MXRA5 MAP1B FAT1 ZFHX4 TENM3

5.22e-0619799663b63c6b2f842adb87bc83222ff86796bd9b58f6
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ANK2 MAP1B SYNM ASAP2 TENM3 ARHGEF26

5.22e-06197996b2f4d7c301c0b24003374923b31d6d058e40b213
ToppCell10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

NDNF MXRA5 MAP1B FAT1 ZFHX4 TENM3

5.22e-06197996fb50903b87498b400c8e16e6a561b6d9458e5d97
ToppCellAT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id

NDNF ABCA3 TMEM63B PTPRF DCBLD2 ACSS3

5.22e-061979968b5d4e1c33a57c899c51feb9a6f347232f8910a3
ToppCellwk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

GPR34 SAMSN1 PCDH12 EPB41L3 TPP1 SIGLEC11

5.53e-061999967c19f1b1f4369edd035ca9cdcf4e653771fc4648
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

AFF3 SYNPO PCDH12 HPGD SCARB1 NRG3

5.53e-06199996dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MXRA5 ANK2 RALGPS2 TENM3 VCAN GFPT2

5.53e-06199996e1849505b92820a219c5a2c35492bdd55579fb48
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MXRA5 ANK2 XYLT1 TENM3 VCAN GFPT2

5.53e-061999968b86c69aaf60feff53aa782559cfece7342a23de
ToppCellLPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PCDH12 ASAP2 PTPRM HPGD DISP1 DYNC1H1

5.69e-0620099672ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type.

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM

5.69e-062009968f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type.

MIS18BP1 BARD1 PRC1 RRM1 WDR76 BLM

5.69e-06200996a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

NDNF ABCA3 TMEM63B EPB41L3 PTPRF ARHGEF26

5.69e-062009962dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellLPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PCDH12 ASAP2 PTPRM HPGD DISP1 DYNC1H1

5.69e-062009965c092b2ecc081b5d04476c56333c338cd89ab984
ToppCellNeuronal|World / cells hierarchy compared to all cells using T-Statistic

MAP1B PAK5 AFF3 CNKSR2 MAN1A2 NRG3

5.69e-0620099648d801219bc771d6c7e151dc88ca4c179988de85
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AFF3 PCDH12 PTPRM HPGD SCARB1 DISP1

5.69e-06200996b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCellLPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

AFF3 PCDH12 PTPRM HPGD SCARB1 DISP1

5.69e-062009967034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NDNF MXRA5 MAP1B FAT1 ZFHX4 TENM3

5.69e-062009963c898e81444b001835c3f1bbc68183078701b135
ToppCellControl_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

AFF3 PCDH12 PTPRM HPGD SCARB1 DISP1

5.69e-06200996abf4ba5fcb54cdeada0da1a8b956a30aa47679e4
ToppCell10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NDNF MXRA5 MAP1B FAT1 ZFHX4 TENM3

5.69e-062009963eca8ffeb41b664fbdbbd70b375c5d953503ab29
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

AFF3 PCDH12 HPGD SCARB1 NRG3 DISP1

5.69e-06200996105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCellE16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like|E16.5-samps / Age Group, Lineage, Cell class and subclass

TPO PAK5 CLSTN1 XYLT1 DISP1

1.15e-051329959633653dba1edee47d915212fb6e68426da49de5
ToppCell343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

MXRA5 AFF3 PCDH12 HPGD CABIN1

1.48e-051399952fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

MXRA5 AFF3 PCDH12 HPGD CABIN1

1.48e-051399955970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPR34 HDAC8 IGDCC3 SYNPO NISCH

1.54e-05140995af9efcbaeeae69fcdac4a15fa244728b65915564
ToppCellE16.5-samps|World / Age Group, Lineage, Cell class and subclass

MIS18BP1 RRM1 NOP58 VCAN RBM5

2.07e-05149995e94d075f68c1c70c89fab50b1b765b5dda650d09
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NDNF FAT1 PTPRM VCAN GFPT2

2.28e-05152995fed80b467ec9e30c7f98bed6cc4f8c583b715e9e
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ANK2 AFF3 RALGPS2 SYNPO RBPMS2

2.58e-05156995d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

XYLT1 FAT1 TENM3 VCAN NRG3

2.58e-05156995dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

XYLT1 FAT1 TENM3 VCAN NRG3

2.58e-05156995abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

MXRA5 AFF3 PCDH12 HPGD DISP1

2.67e-0515799584f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

MANBA MYO7B ST14 HPGD ACSS3

2.67e-051579956a0aa66964eecbbc232abf1d2e6c8422e4ce69d0
ToppCellBasal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

ANKRD31 MXRA5 PAK5 CNKSR2 SHROOM2

2.92e-05160995b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d
ToppCell367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MANBA MYO7B ST14 HPGD ACSS3

3.01e-0516199522fea192cd5f6d3544533d8b10e1d74dfedf0f05
ToppCellHealthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

MAP1B AFF3 RALGPS2 CNKSR2 PLEKHH1

3.19e-05163995d84bd41b4494c7d5c7f88d511bfe481fb12f079d
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NDNF FAT1 PTPRM VCAN GFPT2

3.19e-051639958d17f44faf0549fe71a9a45f811f50d767275414
ToppCellHealthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass

MAP1B AFF3 RALGPS2 CNKSR2 PLEKHH1

3.19e-051639950f723ec2503afa1b3ebb0754972438ffb6e6179d
ToppCellmild_COVID-19_(asymptomatic)-B_cell|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

RALGPS2 SYNPO CNKSR2 METTL25 ARHGEF26

3.28e-05164995e4d43af7eb04d55328791b554bdf3a7ce6818027
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells)

NDNF PCDH12 HPGD SCARB1 DISP1

3.48e-0516699530a991fc3275b571d53bd0976df4789e5d40b01d
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells)

NDNF PCDH12 HPGD SCARB1 DISP1

3.48e-0516699576b4cd32698900797ec009f17e50ea7ae36b85f4
ToppCellControl-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class

MAP1B MUC16 FAT1 ZFHX4 GFPT2

3.48e-051669951ed3788257e14f097862b999f020bfe2a57de52b
ToppCellEndothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

ANK2 MAP1B SYNM PCDH12 ZFHX4

3.48e-05166995c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MIS18BP1 BARD1 PRC1 WDR76 BLM

3.58e-05167995bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RRM1 WDR76 ST14 PLEKHH1 ALMS1

3.68e-0516899508f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

NDNF PCDH12 HPGD SCARB1 DISP1

3.90e-05170995f0b0d2d0402de3ed7322284a599646db43475761
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

NDNF PCDH12 HPGD SCARB1 DISP1

3.90e-05170995054360a3b05f5e41221c98b122d241b1affad26a
ToppCellPND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MIS18BP1 BARD1 SAMSN1 PRC1 VCAN

4.01e-051719956e7ade1d14a3ec4c566476aac3eb509bd2661e39
ToppCellEndothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

MAP1B SYNM PCDH12 ZFHX4 TENM3

4.01e-0517199507ff7059071da83da1d8f266a586573920d75b58
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MIS18BP1 BARD1 PRC1 RRM1 WDR76

4.12e-051729952b6cd84c946b1e800caba452ae70145ea285fec1
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD31 MIS18BP1 LCA5L RRM1 WDR76

4.24e-051739959f892d756d05e573af018db64edb130ff187ad47
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRC1 RRM1 WDR76 BLM HPGD

4.35e-05174995c988471207ba06195bc3e41056435e8c31c20bbe
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CCDC14 ANK2 BLM NOP58 NCOA7

4.35e-051749959bb8159a62640756d18ecbade3bf32bcbb7dd590
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

MXRA5 TRIO FAT1 RBM5 DYNC1H1

9.40e-0650625GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
DiseaseN-acetyltyrosine measurement

ALMS1 RAB11FIP5

1.62e-046982EFO_0020021
Diseasecognitive function measurement, self reported educational attainment

AFF3 PPARG ALMS1 PTPRF SND1 RBM5 RAB11FIP5

1.86e-04355987EFO_0004784, EFO_0008354
DiseaseN-acetylkynurenine (2) measurement

ALMS1 RAB11FIP5

3.87e-049982EFO_0800083
Diseaseplasma renin activity measurement

TENM3 XIRP2

3.87e-049982EFO_0006828
DiseaseN-acetylleucine measurement

ALMS1 RAB11FIP5

3.87e-049982EFO_0800116
Diseaseneuroblastoma

TRIO BARD1 SAMSN1 ASAP2

6.16e-04116984EFO_0000621
DiseaseN-delta-acetylornithine measurement

ALMS1 RAB11FIP5

7.05e-0412982EFO_0800067
DiseaseN-acetylglutamine measurement

ALMS1 RAB11FIP5

8.32e-0413982EFO_0800017
DiseaseN-acetylarginine measurement

ALMS1 RAB11FIP5

1.27e-0316982EFO_0021429
Diseasediastolic blood pressure, systolic blood pressure

ANK2 MAP1B RALGPS2 PPARG XYLT1 ALMS1 HPGD RBPMS2

1.78e-03670988EFO_0006335, EFO_0006336
Diseaseasthma, response to diisocyanate

CLSTN1 BLM ASAP2 TENM3 VCAN

1.81e-03261985EFO_0006995, MONDO_0004979
Diseasevisceral adipose tissue measurement, body mass index

PCDHAC2 CNKSR2 SIK3

3.08e-0387983EFO_0004340, EFO_0004765

Protein segments in the cluster

PeptideGeneStartEntry
SPLSDASKHKYTSED

AFF3

881

P51826
YFLDRSSKTSPDISH

nan

111

Q9N2K0
YFLDRSSKTSPDISH

nan

111

Q9N2J8
KYTEFDSTVTHVVVP

BARD1

596

Q99728
ESYTTLPEATEKSHF

VCAN

2191

P13611
PEKDHSSKSATSQVY

FBXW10

181

Q5XX13
TSEFKPGYSLHDTSV

GPR34

356

Q9UPC5
DFSTSDPTTEFEKFH

HTR1E

246

P28566
ADQKTETLPVHSTSY

ALMS1

1651

Q8TCU4
LSTVTSSFYSHTEKP

ALMS1

1751

Q8TCU4
AYIPSHSDAAKTVTE

ABCA3

81

Q99758
VHTIEKSSTSRPDAY

BCAP29

76

Q9UHQ4
DTPVASRKEDTYVHF

AIDA

206

Q96BJ3
DIVEKHTASTFDPYV

ARHGEF26

516

Q96DR7
TLYVDGTSHEPFSVT

CLSTN1

471

O94985
KLETNYSFTHSEPLS

CCDC14

696

Q49A88
YSFTHSEPLSTIKNE

CCDC14

701

Q49A88
SCTAPEKTTYEETHI

DISP1

1201

Q96F81
HTIRYDFKPASIDTS

EAF1

31

Q96JC9
YTTELTPAISHAAFT

RBPMS2

161

Q6ZRY4
SPKLFTHKRTYSDEA

RAB11FIP5

296

Q9BXF6
TYTLSPSEHFALDVI

PCDH12

171

Q9NPG4
SSEESYKHEGLAETP

ANK2

2226

Q01484
PEKDHSSKSATSQVY

FBXW10B

181

O95170
TEATDKDHEFYVSSP

ANKRD31

1566

Q8N7Z5
SPKFHTTTYSTERSE

NRG3

271

P56975
SHLDSLSKPSEYSDL

PAK5

201

Q9P286
IVEPSVHTYFAIDSS

FAT1

1811

Q14517
SSITHERPATYKDTA

MUC16

5396

Q8WXI7
TSEKESYSSVPAYSE

MUC16

6601

Q8WXI7
HKSEVKTYDPSGDST

NOP58

421

Q9Y2X3
VYFFPSSTHPEDTDK

OR1S1

271

Q8NH92
SDSKTAPHLQDYTVE

LILRA4

431

P59901
FQHLVSDLEPSTAYS

IGDCC3

481

Q8IVU1
YSPTFSDSTSAVKEK

MAP1B

1796

P46821
SFYKHQSSPDLSSEE

MIS18BP1

761

Q6P0N0
VAETHEDYKAPTASS

ASAP2

11

O43150
YSPLTSFITADSELH

METTL25

356

Q8N6Q8
VKIPSDTFYDHEDTT

DAG1

516

Q14118
YIDHDIAFTPQSTSK

TPO

236

P07202
SHVLSYVSKAESTPE

GPS1

216

Q13098
DTHFKVYATTTPESD

NDNF

156

Q8TB73
HDTEDYPKVSSTKSV

LCA5L

346

O95447
STKYVFDSAPSHSIS

ODF3

111

Q96PU9
EKETYVPAAESSSHQ

RBM5

501

P52756
KTIQETPHSEDYSIE

HEMGN

341

Q9BXL5
ATKTPSSDVLVFDYT

RBBP4

141

Q09028
SSDVLVFDYTKHPSK

RBBP4

146

Q09028
VYFFPSSTHPEDTDK

OR1S2

271

Q8NGQ3
ESYYKETLSVPTVEH

THAP12

571

O43422
SVQTYELSPSEHFEL

PCDHAC2

181

Q9Y5I4
TSFHDSYLAVSPDIT

CEFIP

46

Q711Q0
EEFSKTPYTIENSSH

BFAR

221

Q9NZS9
REHPETSSATKVSYD

BCLAF3

266

A2AJT9
DEEIPVSSHYFASKT

BLM

1316

P54132
PEFDSYKTSTVSADL

CABIN1

991

Q9Y6J0
TESSKFAYKTIELPH

GFPT2

626

O94808
PSKSYVNSHFITAEE

EFCAB6

716

Q5THR3
KTEVSSSIYFHKPRE

GPR37L1

456

O60883
YKIEHTETDTVDPRS

TMEM63B

741

Q5T3F8
APTTHTEEYSGEEKT

PRMT5

171

O14744
VSFYLSADHELLSPT

MANBA

771

O00462
FSGVKDVYSSTPTHD

MAN1A2

571

O60476
SEDSPYETLHSFISN

DYNC1H1

141

Q14204
KAVDHEETPVRYSSS

DCBLD2

586

Q96PD2
TLSSEIPDHEFFTAY

HDAC8

326

Q9BY41
VTFSPDHESLYFSDK

CFAP74

1441

Q9C0B2
SSHDDKSTFEETCPY

C18orf21

31

Q32NC0
PVVHTETKTITYESS

EPB41L3

976

Q9Y2J2
STKTSTYEYTDIPFH

OLFM3

421

Q96PB7
QHKVTFDPTSSYTLE

PTPRF

556

P10586
YPDETHTMASDTSSL

PTPRM

841

P28827
SSSAESEDLAVHLYP

RALGPS2

441

Q86X27
TTSKGIHFQDYDTTP

HPGD

246

P15428
IKPDQFTYTSDHFET

EPRS1

261

P07814
TARVSTPHLETYAKD

SLC9B1P1

221

A6NJY1
TEASADSFPDTKVTY

SYNM

656

O15061
ATVSPSSSDAEYDKL

NCOA7

176

Q8NI08
EKYVIESSSHTPELA

SYNPO

736

Q8N3V7
HTDFTPSPYDTDSLK

SAMSN1

171

Q9NSI8
TTVDFSSISTPHYED

PPARG

66

P37231
ASTYSEFAKDPSLSD

PRC1

576

O43663
TDILLSYKHPEVSFS

SIK3

1301

Q9Y2K2
SSPSTDHYKQEASVE

SHROOM2

921

Q13796
SYKPVFVTEITDDLH

SND1

681

Q7KZF4
FQPSKSHGSESDYIV

SCARB1

121

Q8WTV0
EYKTHFAASVTDPER

ACSS3

61

Q9H6R3
SVFSDTATPDIKSHY

CIB1

96

Q99828
PYVEAKHSRLSSTET

CNKSR2

721

Q8WXI2
EYEETFKPSSVVSTS

XIRP2

221

A4UGR9
QPTSLEHYKSDASFS

ZFHX4

2166

Q86UP3
DILIESTAEFTHYKP

XYLT1

796

Q86Y38
AETAATLTTKHPDYA

RRM1

61

P23921
PYHKESAVTAFSEGS

ST14

136

Q9Y5Y6
HSSRVKFTYPSEEEI

NISCH

1311

Q9Y2I1
THYFIKTTTPESDLG

TENM3

2546

Q9P273
SHSRKEETVTVYPAD

UCK2

116

Q9BZX2
SESFSSIEKPSITYE

SUCO

781

Q9UBS9
EPEHKLQRTSSYSTD

PLEKHH1

556

Q9ULM0
LTEHTKSIASAYFSP

WDR76

491

Q9H967
HETFITSSGKSEYIE

VIRMA

1596

Q69YN4
EAPSTTEYSEIKIHT

SIGLEC11

661

Q96RL6
PKSEHIVSEYIDTFF

TRIO

2066

O75962
HPTISNEEKTYIETS

SLC17A8

276

Q8NDX2
YQEEAVTKFLSSSPH

TPP1

421

O14773
TLDTVYEKPTHEETA

MXRA5

926

Q9NR99
LSTMHEEYEFVSPSS

MYO7B

1471

Q6PIF6